$COGT
Cogent Biosciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is COGT down today? It is at $41.63 (-1.53%), and our scanner flagged it 43 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment COGT spikes, and full due diligence on COGT — key stats, earnings, dilution and insider activity. Free.
Get free $COGT alerts the moment volume spikes
Our scanner flagged $COGT 43 times in the last 30 days. Create a free account to track $COGT, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $41.63
- Change today
- -1.53%
- Previous close
- $42.27
- 52-week range
- $10.38 – $43.73
- Market cap
- $7.22B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 16.6M ▲ +1% vs prior · as of 2026-07-15
- Days to cover
- 6.7d
- Avg daily volume
- 2.4M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.4x
- 1h
- 0.4x
- 1D
- 0.0x
Get free COGT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $COGT down today?
Here is the latest on COGT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for COGT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystShareholder Vote, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying1 buys, 1 sells last 3 months (8/13 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Robbins Andrew R Officer | Sold (automatic/other) | -160K 0.09% of company | sold 24% | 498K | n/a | May 19, 26 |
Robbins Andrew R Officer | Acquired (grant/award) | +160K 0.09% of company | n/a | 160K | n/a | May 19, 26 |
Fairmount Funds Management Llc Director | Acquired (grant/award) | +7.00M 4.1% of company | added 100% | 12.50M | n/a | Mar 31, 26 |
Fairmount Funds Management Llc Director | Sold (automatic/other) | -7.00M 4.1% of company | sold 56% | 5.50M | $242.6M at $34.66 | Mar 31, 26 |
Fairmount Funds Management Llc Director | Sold (automatic/other) | -3.50M 2.0% of company | sold 39% | 5.50M | $127.4M at $36.40 | Jan 22, 26 |
Sachs Jessica Officer | Sold (automatic/other) | -83K 0.05% of company | sold 38% | 134K | $3.2M at $38.70 | Dec 26, 25 |
Robinson John Edward Officer | Sold (automatic/other) | -90K 0.05% of company | sold 39% | 140K | $3.5M at $38.74 | Dec 26, 25 |
Green John L. Officer | Sold (automatic/other) | -77K 0.05% of company | sold 37% | 132K | $3.0M at $38.68 | Dec 26, 25 |
Kearns Evan Officer | Sold (automatic/other) | -65K 0.04% of company | sold 37% | 109K | $2.5M at $38.70 | Dec 26, 25 |
Green John L. Officer | Acquired (grant/award) | +350K 0.2% of company | added 100% | 354K | n/a | Dec 17, 25 |
Green John L. Officer | Sold (automatic/other) | -145K 0.08% of company | sold 41% | 209K | $5.7M at $39.45 | Dec 17, 25 |
Sachs Jessica Officer | Acquired (grant/award) | +370K 0.2% of company | added 100% | 371K | n/a | Dec 17, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $COGT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- Priced at $31.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$COGT Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$COGT Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to COGT
Comparable names in pharmaceutical preparations, closest in size first.
COGT stock FAQ
Why is $COGT down today?
Here is the latest on COGT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for COGT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the COGT stock price today?
COGT last traded at $41.63, down 1.53% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live COGT alerts?
The COGT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged COGT 43 times in the last 30 days.
What exchange is COGT on?
COGT (Cogent Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $7.22B in the PHARMACEUTICAL PREPARATIONS sector.
Is COGT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge COGT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.